Immune tolerance in an inhibitor patient with severe hemophilia A - Comparison of two different treatment schedules including rituximab

被引：1
|
作者：
Wermes, C
Wieland, I
Prondzinski, MVD
Sykora, KW
机构：
来源：
34th Hemophilia Symposium | 2005年
关键词：
D O I：
10.1007/3-540-27022-1_41
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：253 / 256
页数：4
相关论文
共 50 条
  • [1] Successful treatment of immune tolerance induction with rituximab in a patient with severe hemophilia B and inhibitor
    Kobayashi, Ryoji
    Sano, Hirozumi
    Suzuki, Daisuke
    Kishimoto, Kenji
    Yasuda, Kazue
    Honjo, Ryota
    Hirose, Mieko
    Fujita, Shoji
    Abe, Shuji
    Kobayashi, Kunihiko
    BLOOD COAGULATION & FIBRINOLYSIS, 2015, 26 (05) : 580 - 582
  • [2] Rituximab and immune tolerance in severe hemophilia A: a consecutive national cohort
    Collins, P. W.
    Mathias, M.
    Hanley, J.
    Keeling, D.
    Keenan, R.
    Laffan, M.
    Perry, D.
    Liesner, R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (05) : 787 - 794
  • [3] Prophylactic treatment and Rituximab subsequent immune tolerance induction therapy to improve inhibitor eradication on resistant ITI in severe hemophilia A patients with inhibitor
    Chen, Yeu-Chin
    Cheng, Shin-Nan
    HAEMOPHILIA, 2016, 22 : 69 - 69
  • [4] Novel treatment approaches in combination with rituximab for immune tolerance induction in severe Hemophilia B
    Brandow, Amanda M.
    Punzalan, Rowena C.
    Stephany, Karen
    Hesell, Craig
    Gill, Joan C.
    BLOOD, 2007, 110 (11) : 61B - 62B
  • [5] Immune tolerance in hemophilia and treatment of hemophiliacs with an inhibitor
    Mariani, G
    Brackmann, HH
    HAEMATOLOGICA, 2001, 86 (03) : 225 - 226
  • [6] Immune tolerance induction in children with severe hemophilia A and inhibitor in Poland
    Klukowska, A.
    Laguna, P.
    Dobaczewski, G.
    Janik-Moszant, A.
    Kamienska, E.
    Koltan, A.
    Pietrys, D.
    Waleszkiewicz-Majewska, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1069 - 1070
  • [7] Changes in Epitope Specificity, Inhibitor Titer, and Antibody Titer in a Patient with Severe Hemophilia A Undergoing Immune Tolerance Therapy with Rituximab and Recombinant Factor VIII
    Chapman, Robin
    Cox, Courtney
    Dunn, Amy
    Meeks, Shannon
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 : S165 - S165
  • [8] Low Dose Immune Tolerance Treatment In Severe Hemophilia A And High Responder Inhibitor: One Center Experience
    Kavakli, K.
    Balkan, C.
    HAEMOPHILIA, 2017, 23 : 90 - 90
  • [9] The results of late immune tolerance induction in children with severe hemophilia A and inhibitor in Poland
    Klukowska, Anna
    Laguna, Pawel
    Waleszkiewicz-Majewska, Beata
    HAEMOPHILIA, 2014, 20 : 44 - 44
  • [10] The efficacy of the rituximab-containing rescue-regimen for severe hemophilia A inhibitor children who relapsed following successful immune tolerance induction with rituximab in China
    Li, Zhengping
    Li, Zekun
    Sun, Jie
    Cheng, Xiaoling
    Liu, Guoqing
    Yao, Wanru
    Huang, Kun
    Ai, Di
    Chen, Zhenping
    Li, Gang
    Zhen, Yingzi
    Poon, Man-Chiu
    Wu, Runhui
    THROMBOSIS RESEARCH, 2023, 223 : 123 - 126
12345